Denmark Outlines Vision For Decentralized Trials Beyond COVID-19
Executive Summary
The Danish medicines regulator has set out its expectations on key elements of decentralized clinical trials as part of Denmark’s ongoing effort to develop a robust regulatory framework in this area.
You may also be interested in...
Undertaking Decentralized Clinical Trials In The UK ‘Should Not Be A Luxury’
UK needs to do more to address the current uncertainty among sponsors on how decentralized clinical trials can generate regulatory-grade data.
Undertaking Decentralized Clinical Trials In The UK ‘Should Not Be A Luxury’
UK needs to do more to address the current uncertainty among sponsors on how decentralized clinical trials can generate regulatory-grade data.
EU Picks Up The Pace On Home Delivery Of Study Drugs
As drug companies get “really organized” about incorporating patient-centric elements in their clinical trials, a senior executive at a global courier company says the time is ripe for the EU to produce harmonized guidance on easing a clinical trial participant’s access to the study drug.